[1]
G. Cechim, J. H. Ellwanger, V. de Lima Kaminski, M. Berger, e J. A. Bogo Chies, “Increased systemic IL-6 levels indicate inflammation as a determinant component in renal cell carcinoma development”, Clin Biomed Res, vol. 41, nº 3, out. 2021.